FDA Inspection
Jubilant DraxImage Inc., dba Jubilant RadiopharmaJubilant DraxImage Inc., dba Jubilant Radiopharma – FDA Inspection, Mar 23, 2026
Record Details
This FDA Inspection record concerns Jubilant DraxImage Inc., dba Jubilant Radiopharma, with an inspection on March 23, 2026, issued by the New Orleans District Office, covering human drugs.
- Inspection Date
- March 23, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 30cde839-f0c5-4e2e-8665-b804efa6e542
Inspection Facts
- Inspection number
- 1308792
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.30(c)Contact surfaces
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Jubilant DraxImage Inc., dba Jubilant Radiopharma
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jubilant DraxImage Inc., dba Jubilant Radiopharma
- FDA Inspection 984555 - 2016-09-13
- FDA Inspection 827247 - 2013-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.